Journal Information
Vol. 11. Issue 2.
Pages 135-154 (March - April 2005)
Share
Share
Download PDF
More article options
Vol. 11. Issue 2.
Pages 135-154 (March - April 2005)
Artigo Original/Original Article
Open Access
Cancro do pulmão – O que mudou em duas décadas
Lung cancer – What has changed in two decades
Visits
5737
Maria Sucena1,
Corresponding author
gusmaria23@hotmail.com

Correspondência: Serviço de Pneumologia do Hospital de S. João Alameda Professor Hernâni Monteiro, 4202-451 Porto Telefone: 225512214
, Gabriela Fernandes1, Henrique Queiroga2,3, Venceslau Hespanhol2,4
1 Interna Complementar de Pneumologia do Hospital de S. João
2 Assistente Hospitalar Graduado de Pneumologia do Hospital de S. João
3 Professor Auxiliar de Medicina da Faculdade de Medicina da Universidade do Porto
4 Professor Associado de Medicina da Faculdade de Medicina da Universidade do Porto
This item has received

Under a Creative Commons license
Article information
Resumo

O cancro do pulmão (CP) é um problema major de saúde pública, sendo a neoplasia mais comum no sexo masculino e a que maior mortalidade determina em ambos os sexos. Há duas décadas observava-se um predomínio do carcinoma epidermóide; no entanto, actualmente, o adenocarcinoma é o tipo histológico mais frequente.

Foi objectivo deste trabalho retrospectivo a comparação dos dados demográficos e dos factores relacionados com a doença em doentes cujo diagnóstico de CP foi efectuado nos períodos compreendidos entre 1979-1982 e 1999-2002 no H. S. João.

Nos oito anos referentes ao estudo foi diagnosticado CP em 750 doentes. Dos 236 doentes cujo diagnóstico foi efectuado entre 1979-1982, 84,3% eram do sexo masculino, com uma idade média de 60,0±10,0 anos. O tipo histológico predominante foi o carcinoma epidermóide (46,2%). No período entre 1999-2002 foi diagnosticado CP em 514 doentes (83,9% sexo masculino; idade média 64,7±10,8 anos), com um predomínio do adenocarcinoma (47,1%). Ao longo dos 20 anos analisados verificaram-se diferenças estatisticamente significativas em relação aos hábitos tabágicos (aumento da percentagem de fumadores; 73,7% vs 82,4%), idade dos doentes (aumento da idade média), tipo histológico (aumento da percentagem de adenocarcinoma e diminuição do carcinoma epidermóide e carcinoma de pequenas células) e tratamento (diminuição da proporção de doentes submetidos apenas a terapêutica de suporte; 26% vs 19%).

Como conclusão, saliente-se a evolução dos tipos histológicos nos últimos 20 anos e um menor recurso ao tratamento sintomático como única opção terapêutica.

Rev Port Pneumol 2005; XI (2): 135-154

Palavras chave:
Cancro do pulmão
histologia
estado geral
estádio
tratamento
Abstract

Lung cancer (LC) is a major public health problem and it is the most common form of cancer in men. It remains the most common cause of cancer death in men and women. In the initial decades of the smoking-caused epidemic, squamous cell carcinoma was the most frequent type. Recently there was a shift toward predominance of adenocarcinoma.

The aim of our retrospective study was to compare the demographic factors and factors connected with the disease in patients whose LC was diagnosed in two distinct periods in H.S.João (1979-1982 and 19992002).

A total of 750 LC were diagnosed. Between 19791982 a total of 236 patients were diagnosed LC (84.3% male; mean age 60.0±10.0). The most common histological type was squamous cell (46.2%). A total of 514 LC were diagnosed during the period 1999-2002 (83.9% male; mean age 64.7±10.8) and adenocarcinoma was the most frequent (47.1%). There were significant differences, between the two periods analysed concerning smoking (increase in the number of smokers; 73.7% vs 82.4%), age (increase in the mean age of patients) and histology (higher percentage of adenocarcinoma and reduction of squamous cell and small-cell lung cancer). The percentage of patients treated symptomatically decreased significantly in 20 years (26% vs 19%).

As a conclusion we can say that there was an evolution of histological types in the last two decades and a reduction in the number of patients submitted to symptomatic treatment alone.

Rev Port Pneumol 2005; XI (2): 135-154

Key words:
Lung cancer
histology
performance status
stage
treatment
Full text is only aviable in PDF
Bibliografia/Bibliography
[1.]
A. Jemal, A. Thomas, T. Murray, et al.
Cancer statistics 2002.
CA Cancer J Clin, 52 (2002), pp. 23-47
[2.]
C. Montero, M. Rosales, I. Otero, M. Blanco, G. Rodriguez, S. Peterga, S. Pita, H. Verea.
Cancer de pulmon en el área sanitária de A Coruna: incidência, abordaje clínico y supervivencia.
Arch Bronconeumol, 39 (2003), pp. 209-216
[3.]
S.G. Spiro, J.C. Porter.
Lung cancer – where are we today? Current advances in staging and nonsurgical treatment.
Am J Respir Crit Care Med, 166 (2002), pp. 1166-1196
[4.]
M.J. Gomes, R. Sotto-Mayor.
Tratado de Pneumologia, 1ª edição,
[5.]
Diagnosis and Management of Lung Cancer: ACCP evidence-based guidelines.
Chest, 123 (2003), pp. 1S-338S
[6.]
A. Chung.
Lung cancer cell type and occupational exposure.
Epidemiology of lung cancer, pp. 413-436
[7.]
A. Charloux, E. Quoix, N. Wolkove, D. Small, G. Pauli, H. Kreisman.
The increasing incidence of lung Adenocarcinoma: reality or artefact? A review of the epidemiology of lung cancer adenocarcinoma.
Int J Epidemiol, 26 (1997), pp. 14-23
[8.]
R.G. Vincent, J.W. Pickren, W.W. Lane, L. Bross, H. Takita, L. Honten, et al.
The changing histopathology of lung cancer.
Cancer, 39 (1977), pp. 1647-1655
[9.]
National Cancer Institute (NCI).
The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of US cigarettes.
Monograph 7,
[10.]
E.L. Wynder, J.E. Muscat.
The changing epidemiology of smoking and lung cancer histology.
Environ health Perspect, 103 (1995), pp. 143-148
[11.]
D. Hoffmann, I. Hoffman.
The changing cigarette, 1950-1995.
J Toxicol Environ Health, 50 (1997), pp. 307-364
[12.]
Travis WD, et al. Histological typing of lung and pleural tumours (3ª Ed.). World Health Organization. Springer.
[13.]
M.M. Oken, R.H. Creech, D.C. Torney, et al.
Toxicity and response criteria of the Eastern Cooperative Oncology Group.
Am J Clin Oncol, 5 (1982), pp. 649-655
[14.]
C.F. Mountain.
Revision in the International System for Staging Lung Cancer.
Chest, 111 (1997), pp. 1710-1717
[15.]
R. Sotto-Mayor.
Terapêutica do carcinoma pulmonar não de pequenas células.
Rev Port Pneumol, VIII (2002), pp. 237-259
[16.]
F. Levi, S. Franceschi, C. La Vecchia, L. Randimbison, V.C. Te.
Lung cancer trends by histological type in Vaud and Neuchâtel, Switzerland, 1974-1994.
Cancer, 79 (1997), pp. 906-914
[17.]
J.M. Mane, J. Estape, J. Sanchez-Lloret, et al.
Age and clinical characteristics of 1433 patients with lung cancer.
Age Ageing, 23 (1994), pp. 28-31
[18.]
E. Silverberg, J.A. Lubera.
Cancer statistics.
CA Cancer J Clin, 38 (1988), pp. 5-22
[19.]
C. Gridelli, F. Perrone, S. Monfardini.
Lung cancer in the elderly.
Eur J Cancer, 33 (1997), pp. 2313-2314
[20.]
J.S. Brown, D. Eraut, C. Trask, A.G. Davison.
Age and the treatment of lung cancer.
Thorax, 51 (1996), pp. 564-568
[21.]
D. Coggon, E.D. Acheson.
Trends in lung cancer mortality.
Thorax, 38 (1983), pp. 721-723
[22.]
C.K. Connolly, W.G. Jones, J. Thorogood, C. Head, M.F. Muers.
Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire region of England 1976-1983.
Br J Cancer, 61 (1990), pp. 579-583
[23.]
M.L.G. Janssen-Heijnen, G. Gatta, D. Forman, R. Capocaccia, J.W.W. Coebergh.
Variation in survival of patients with lung cancer in Europe 1985-1989.
Eur J Cancer, 34 (1998), pp. 2191-2196
[24.]
M.L.G. Janssen-Heijnen, R.M. Schipper, P.P.A. Razenberg, M.A. Crommelin, J.W. Coeberg.
Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study.
Lung Cancer, 21 (1998), pp. 105-113
[25.]
L. Balducci.
Geriatric oncology: challenge for the new century.
Eur J Cancer, 36 (2000), pp. 1741-1754
[26.]
I.S. Fentiman, V. Tirelli, S. Monfardini, et al.
Cancer in the elderly: why so badly treated?.
Lancet, 28 (1990), pp. 1020-1022
[27.]
J.F. Piccirillo, A.R. Feinstein.
Clinical symptoms and comorbidity: significance for the prognostic classification of cancer.
Cancer, 77 (1996), pp. 834-842
[28.]
A.R. Feinstein, C.K. Wells.
A clinical-severity staging system for patients with lung cancer.
Medicine, 69 (1990), pp. 1-33
[29.]
R. Doll, R. Peto.
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.
J Epidemiol Community Health, 32 (1978), pp. 303-313
[30.]
US Department of Health, and Human Services (USDHHS), Public Health Service, Centers for Disease Control, and Prevention (CDC). Cigarette smoking: attributable mortality and years of potential life lost, United States, 1950-1990.
MMWR Morb Mortal Kkly Rep, 42 (1993), pp. 37-39
[31.]
US Department of health, and Human Services (USDHHS).
The health benefits of smoking cessation: a report of the Surgeon General: USDHHS Publication Nº 90-8416.
US Government Printing Office, (1990),
[32.]
Z. Hrubec, J.K. McLaughlin.
Former cigarette smoking and mortality among US veterans: a 26-year followup, 1954-1980.
Changes in cigarette-related disease risks and their implications for prevention and control, pp. 501-530
[33.]
M.A. O’Rourke, J.R. Feussner, P. Feigl, J. Laszlo.
Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly.
JAMA, 258 (1987), pp. 921-926
[34.]
M.A. O’Rourke, J. Crawford.
Lung cancer in the eldlery.
Clin Geriatr Med, 3 (1987), pp. 595-623
[35.]
H. Anton-Culver, B.D. Culver, T. Kurosaki, K.E. Osann, J.B. Lee.
Incidence of lung cancer by histological type from a population-based registry.
Cancer Res, 48 (1988), pp. 6580-6583
[36.]
S.S. Devesa, G.L. Shaw, W.J. Blot.
Changing patterns of lung cancer incidence by histological type.
Cancer Epidemiol Biomarkers Prev, 1 (1991), pp. 29-34
[37.]
T. Zheng, T. Holford, P. Boyle, Y. Chen, B.A. Ward, J. Flannery, et al.
Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut 1960-1989.
Cancer, 74 (1994), pp. 1556-1557
[38.]
W.D. Travis, L.B. Travis, S.S. Devesa.
Lung cancer.
Cancer, 75 (1995), pp. 191-202
[39.]
W.D. Travis, L.B. Travis, S.S. Devesa.
United States lung carcinoma incidence trends. Declining for most histologic types among males, increasing among females.
[40.]
L. Dodds, S. Davis, L. Polissar.
A population based study of lung cancer incidence trends by histological type, 1974-1981.
J Natl Cancer Inst, 6 (1986), pp. 21-29
[41.]
A.H. Wu, B.E. Henderson, D.C. Thomas, T.M. Mack.
Secular trends in histologic types of lung cancer.
J Natl Cancer Inst, 7 (1986), pp. 53-56
[42.]
M.L. Janssen-Heijnen, H.W. Nab, J. van Reek.
Van der heijden LH, Schipper R, Coebergh JW. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960-91.
Eur J Cancer, 31A (1995), pp. 949-952
[43.]
J.H. Olsen.
Epidemiology of lung cancer.
Eur Respir Mon, 1 (1995), pp. 1-17
[44.]
A. Seow, S.W. Duffy, T.P. Ng, et al.
Lung cancer amoung Chinese females in Singapore 1968-1992: time trends, dialect group differences and implications for aetiology.
Int J Epidemiol, 27 (1998), pp. 167-172
[45.]
I.T.M. Kung, K.F. So, T.H. Lam.
Lung cancer in Hong Kong Chinese: mortality and histological types, 1973-1982.
Br J Cancer, 50 (1984), pp. 381-388
[46.]
A. Hanai, T. Benn, I. Fujimoto, C.S. Muir.
Comparison of lung cancer incidence rates by histological type in high and low incidence countries, with reference to the limited role of smoking.
Jpn J Cancer Res (Gann), 79 (1988), pp. 445-452
[47.]
G. Rennert, H.S. Rennert, L. Epstein.
Lung cancer histology in major ethnic groups among the jews, Israel, 1962-1982.
Eur J Epidemiol, 7 (1991), pp. 68-76
[48.]
J.H. Choi, H.C. Chung, N.C. Yoo, H.R. Lee, W. Choi, et al.
Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study.
Lung Cancer, 10 (1994), pp. 287-296
[49.]
A. Russo, P. Crosignani, S. Franceschi, F. Berrino.
Changes in lung cancer histological types in Varese cancer registry, Italy 1976-1992.
Eur J Cancer, 33 (1997), pp. 1643-1647
[50.]
E.L. Wynder, D. Hoffmann.
Smoking and lung cancer: scientific challenges and opportunities.
Cancer Res, 54 (1994), pp. 5284-5295
[51.]
R. Peto.
Overview of cancer time-trend studies in relation to changes in cigarette manufacture.
Tobacco: a major international health hazard: IARC Scientific Publication Nº 74 Lyon: International Agency for Research on Cancer, pp. 211-226
[52.]
S. Benhamou, E. Benhamou, M. Tirmarche, R. Flamant.
Lung cancer and use of cigarettes: a French case-control study.
J Natl Cancer Inst, 74 (1985), pp. 1169-1175
[53.]
G.C. Kabat, S.D. Stellman, E.L. Wynder.
Relation between exposure to environmental tobacco smoke and lung cancer in lifetime nonsmokers.
Am J Epidemiol, 142 (1995), pp. 141-148
[54.]
D.W. Travis, J. Linder, B. Mackay.
Classification, histology, cytology, and electron microscopy.
Lung cancer: principles and practice, pp. 361-395
[55.]
D. Carr.
Histopathology of lung cancer.
Int J Epidemiol, 19 (1990), pp. 8-10
[56.]
R. Makitaro, P. Paakko, E. Huhti, R. Bloigu, V.L. Kinnula.
An epidemiological study of lung cancer: history and histological types in a general population in northern Finland.
Eur Respir J, 13 (1999), pp. 436-440
[57.]
T. Byers, J. Vena, C. Mettlin, M. Swanson, S. Graham.
Dietary vitamin A and lung cancer risk: an analysis by histological subtypes.
Am J Epidemiol, 120 (1984), pp. 769-776
[58.]
F. Mollo, E. Pira.
piolatto G, Bellis D, burlo P, Andreozzi A, et al. Lundg Adenocarcinoma and indicators of asbestos exposure.
Int J Cancer, 60 (1995), pp. 289-293
[59.]
E. Taioli, E.L. Wynder.
Endocrine factors and adenocarcinoma of the lung in women.
J Natl Cancer Inst, 86 (1994), pp. 869-870
[60.]
A. Charloux, M. Rossignal, A. Purohit, et al.
International differences in epidemiology of lung carcinoma.
Lung Cancer, 16 (1997), pp. 133-143
[61.]
C.H. Bouchardy, G. Floretta, M. de Perott, et al.
determinants of long term survival after surgery for cancer of the lung.
Cancer, 86 (1999), pp. 2229-2237
[62.]
S. Spiro.
Management of lung cancer. Remains surgery for cure of non-small cell and chemotherapy for small cell type.
BMJ, 301 (1990), pp. 1287-1288
[63.]
R.J. Fergusson, A. Gregor, R. Dodds, G. Kerr.
Management of lung cancer in South East Scotland.
Thorax, 51 (1996), pp. 569-574
[64.]
R.A. Damhuis, P.R. Schutte.
Resection rates and postoperative mortality in 7899 patients with lung cancer.
Eur Respir J, 9 (1996), pp. 7-10
[65.]
J.C. Roxburgh, J. Thompson, P. Goldstraw.
Hospital mortality and long-term survival after pulmonary resection in the elderly.
Ann Thorac Surg, 51 (1991), pp. 800-803
[66.]
F.A. Shepherd, D.N. Carney.
Treatment of NSCLC: Chemotherapy.
textbook of Lung Cancer, pp. 213-242
Copyright © 2005. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?